載入...
Co-delivery of 2-Deoxyglucose and a Glutamine Metabolism Inhibitor V9302 via a Prodrug Micellar Formulation for Synergistic Targeting of Metabolism in Cancer
The unique metabolic demand of cancer cells suggests a new therapeutic strategy targeting the metabolism in cancers. V9302 is a recently reported inhibitor of ASCT2 amino acid transporter which shows promising antitumor activity by blocking glutamine uptake. However, its poor solubility in aqueous s...
Na minha lista:
| 發表在: | Acta Biomater |
|---|---|
| Main Authors: | , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7105957/ https://ncbi.nlm.nih.gov/pubmed/31958597 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.actbio.2020.01.019 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|